BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hide T, Takezaki T, Nakamura H, Kuratsu J, Kondo T. Brain tumor stem cells as research and treatment targets. Brain Tumor Pathol 2008;25:67-72. [DOI: 10.1007/s10014-008-0237-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Arabzadeh A, Mortezazadeh T, Aryafar T, Gharepapagh E, Majdaeen M, Farhood B. Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review. Cancer Cell Int 2021;21:391. [PMID: 34289841 DOI: 10.1186/s12935-021-02099-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
2 Ghatak S, Hascall VC, Markwald RR, Misra S. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells. Int J Mol Sci 2021;22:E753. [PMID: 33451103 DOI: 10.3390/ijms22020753] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
3 Liu Q, Wang L, Li D, Zhao J, Chen S, Li J. Synergistic effect of STAT3‑targeted small interfering RNA and AZD0530 against glioblastoma in vitro and in vivo. Mol Med Rep 2019;20:3625-32. [PMID: 31485668 DOI: 10.3892/mmr.2019.10596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Yang F, Cui P, Lu Y, Zhang X. Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells. Stem Cell Res Ther 2019;10:233. [PMID: 31375149 DOI: 10.1186/s13287-019-1360-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
5 Kitabayashi T, Dong Y, Furuta T, Sabit H, Jiapaer S, Zhang J, Zhang G, Hayashi Y, Kobayashi M, Domoto T, Minamoto T, Hirao A, Nakada M. Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma. Sci Rep 2019;9:10049. [PMID: 31296906 DOI: 10.1038/s41598-019-46454-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
6 Arzoglou V, Tsitlakidis A, Foroglou N, Polyzoidis K, Makri S, Patsalas I. Does proximity to the subventricular zone and expression of CXCR-4 and nestin affect prognosis in high-grade glioma? Br J Neurosurg 2018;32:614-8. [PMID: 30282472 DOI: 10.1080/02688697.2018.1504881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Rajesh Y, Pal I, Banik P, Chakraborty S, Borkar SA, Dey G, Mukherjee A, Mandal M. Insights into molecular therapy of glioma: current challenges and next generation blueprint. Acta Pharmacol Sin 2017;38:591-613. [PMID: 28317871 DOI: 10.1038/aps.2016.167] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 13.8] [Reference Citation Analysis]
8 Yen SY, Chuang HM, Huang MH, Lin SZ, Chiou TW, Harn HJ. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma. Int J Mol Sci 2017;18:E372. [PMID: 28208648 DOI: 10.3390/ijms18020372] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
9 Tokudome T, Sasaki A, Tsuji M, Udaka Y, Oyamada H, Tsuchiya H, Oguchi K. Reduced PTEN expression and overexpression of miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p by glioblastoma stem-like cells following irradiation. Oncol Lett 2015;10:2269-72. [PMID: 26622832 DOI: 10.3892/ol.2015.3594] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
10 Yang MY, Lee HT, Chen CM, Shen CC, Ma HI. Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells. Int J Mol Sci 2014;15:11013-29. [PMID: 24945311 DOI: 10.3390/ijms150611013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
11 Tanase CP, Enciu AM, Mihai S, Neagu AI, Calenic B, Cruceru ML. Anti-cancer Therapies in High Grade Gliomas. Curr Proteomics 2013;10:246-60. [PMID: 24228024 DOI: 10.2174/1570164611310030007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
12 Qiu B, Zhang D, Wang Y, Ou S, Wang J, Tao J, Wang Y. Interleukin-6 is overexpressed and augments invasiveness of human glioma stem cells in vitro. Clin Exp Metastasis 2013;30:1009-18. [DOI: 10.1007/s10585-013-9599-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
13 Sadahiro H, Yoshikawa K, Ideguchi M, Kajiwara K, Ishii A, Ikeda E, Owada Y, Yasumoto Y, Suzuki M. Pathological features of highly invasive glioma stem cells in a mouse xenograft model. Brain Tumor Pathol 2014;31:77-84. [PMID: 23670138 DOI: 10.1007/s10014-013-0149-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
14 Kahlert UD, Nikkhah G, Maciaczyk J. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett 2013;331:131-8. [PMID: 23268331 DOI: 10.1016/j.canlet.2012.12.010] [Cited by in Crossref: 146] [Cited by in F6Publishing: 163] [Article Influence: 14.6] [Reference Citation Analysis]
15 Bulstrode H, Jones LM, Siney EJ, Sampson JM, Ludwig A, Gray WP, Willaime-Morawek S. A-Disintegrin and Metalloprotease (ADAM) 10 and 17 promote self-renewal of brain tumor sphere forming cells. Cancer Lett 2012;326:79-87. [PMID: 22841667 DOI: 10.1016/j.canlet.2012.07.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
16 Qiu B, Sun X, Zhang D, Wang Y, Tao J, Ou S. TRAIL and paclitaxel synergize to kill U87 cells and U87-derived stem-like cells in vitro. Int J Mol Sci 2012;13:9142-56. [PMID: 22942757 DOI: 10.3390/ijms13079142] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
17 Yang YP, Chang YL, Huang PI, Chiou GY, Tseng LM, Chiou SH, Chen MH, Chen MT, Shih YH, Chang CH, Hsu CC, Ma HI, Wang CT, Tsai LL, Yu CC, Chang CJ. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. J Cell Physiol 2012;227:976-93. [PMID: 21503893 DOI: 10.1002/jcp.22806] [Cited by in Crossref: 96] [Cited by in F6Publishing: 104] [Article Influence: 9.6] [Reference Citation Analysis]
18 Chang C, Chiang C, Song W, Tsai S, Woung L, Chang C, Jeng S, Tsai C, Hsu C, Lee H, Huang C, Yung M, Liu J, Lu K. Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells. Childs Nerv Syst 2012;28:363-73. [DOI: 10.1007/s00381-011-1672-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
19 Qiu B, Zhang D, Tao J, Tie X, Wu A, Wang Y. Human brain glioma stem cells are more invasive than their differentiated progeny cells in vitro. J Clin Neurosci 2012;19:130-4. [PMID: 22153826 DOI: 10.1016/j.jocn.2011.06.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
20 Cho D, Lin S, Yang W, Hsu D, Lin H, Lee H, Lee W, Chiu S. The Role of Cancer Stem Cells (CD133 + ) in Malignant Gliomas. Cell Transplant 2011;20:121-5. [DOI: 10.3727/096368910x532774] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
21 Lukiw WJ, Culicchia F. Genetic Signaling in Glioblastoma Multiforme (GBM): A Current Overview. Neurochemical Mechanisms in Disease 2011. [DOI: 10.1007/978-1-4419-7104-3_24] [Reference Citation Analysis]
22 Hueng D, Sytwu H, Huang S, Chang C, Ma H. Isolation and characterization of tumor stem-like cells from human meningiomas. J Neurooncol 2011;104:45-53. [DOI: 10.1007/s11060-010-0469-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
23 Ma HI, Chiou SH, Hueng DY, Tai LK, Huang PI, Kao CL, Chen YW, Sytwu HK. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation. J Neurosurg 2011;114:651-62. [PMID: 21054139 DOI: 10.3171/2009.11.JNS091396] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
24 Graeme R. CNS Cancers. Burger's Medicinal Chemistry and Drug Discovery 2010. [DOI: 10.1002/0471266949.bmc223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Méndez O, Zavadil J, Esencay M, Lukyanov Y, Santovasi D, Wang SC, Newcomb EW, Zagzag D. Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer 2010;9:133. [PMID: 20515450 DOI: 10.1186/1476-4598-9-133] [Cited by in Crossref: 149] [Cited by in F6Publishing: 158] [Article Influence: 12.4] [Reference Citation Analysis]
26 Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR, Fulton D, Abdulkarim B, Mcmurtry MS, Petruk KC. Metabolic Modulation of Glioblastoma with Dichloroacetate. Science Translational Medicine 2010;2:31ra34-31ra34. [DOI: 10.1126/scitranslmed.3000677] [Cited by in Crossref: 484] [Cited by in F6Publishing: 531] [Article Influence: 40.3] [Reference Citation Analysis]
27 Barbieri F, Pattarozzi A, Gatti M, Aiello C, Quintero A, Lunardi G, Bajetto A, Ferrari A, Culler MD, Florio T. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice. Am J Physiol Endocrinol Metab 2009;297:E1078-88. [PMID: 19706788 DOI: 10.1152/ajpendo.00292.2009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
28 Milsom C, Magnus N, Meehan B, Al-Nedawi K, Garnier D, Rak J. Tissue factor and cancer stem cells: is there a linkage? Arterioscler Thromb Vasc Biol 2009;29:2005-14. [PMID: 19628788 DOI: 10.1161/ATVBAHA.108.177444] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]